SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008679
Filing Date
2017-11-09
Accepted
2017-11-09 15:27:14
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20170930x10q.htm 10-Q 1132213
2 EX-10.1 imgn-20170930ex101bd9885.htm EX-10.1 1899256
3 EX-10.2 imgn-20170930ex102e0b30e.htm EX-10.2 22580
4 EX-31.1 imgn-20170930ex31119ce23.htm EX-31.1 11555
5 EX-31.2 imgn-20170930ex312b45aa8.htm EX-31.2 11597
6 EX-32 imgn-20170930xex32.htm EX-32 10316
7 GRAPHIC imgn20170930ex101bd9885001.jpg GRAPHIC 3358
8 GRAPHIC imgn20170930ex101bd9885002.jpg GRAPHIC 2612
  Complete submission text file 0001558370-17-008679.txt   7747762

Data Files

Seq Description Document Type Size
9 EX-101.INS imgn-20170930.xml EX-101.INS 1189503
10 EX-101.SCH imgn-20170930.xsd EX-101.SCH 46519
11 EX-101.CAL imgn-20170930_cal.xml EX-101.CAL 41916
12 EX-101.DEF imgn-20170930_def.xml EX-101.DEF 211981
13 EX-101.LAB imgn-20170930_lab.xml EX-101.LAB 460067
14 EX-101.PRE imgn-20170930_pre.xml EX-101.PRE 354106
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 171190499
SIC: 2834 Pharmaceutical Preparations